Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

14,461 studies for “lung cancer”

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)Recruiting
NCT05920356Phase 3Updated Aug 21, 2026
Sponsor: Amgen
Non-Small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Austria, Belgium +33 more
Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation
NCT00068003N/AUpdated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Melanoma · Gastrointestinal Cancer · Metastatic Cancer · Breast Cancer
United States
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)Recruiting
NCT07227597Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Small Cell Lung Cancer Extensive Stage
United States, Argentina, Chile, China, Germany +7 more
A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to TreatmentCompleted
NCT05241834Phase 1Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung · Thyroid Neoplasms
United States, France
Septum-guided Segmentectomy for 2-3 cm Clinical Stage IA3 Peripheral Non-Small Cell Lung CancerNot Yet Recruiting
NCT07780591NAUpdated Aug 21, 2026
Sponsor: Shanghai Chest Hospital
Non-Small Cell Lung Cancer
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)Suspended
NCT06694454Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Non-small Cell Lung Cancer (NSCLC) · Carcinoma, Non-Small Cell Lung · Non-Small Cell Lung Carcinoma · Non Small Cell Lung Cancer
United States
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung CancerSuspended
NCT05642195Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Non-Small Cell Lung Cancer · Non-Small Cell Lung Carcinoma · Carcinoma, Non-Small-Cell Lung · Carcinomas
United States
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)Recruiting
NCT07524114N/AUpdated Aug 21, 2026
Sponsor: University Health Network, Toronto
Breast Cancer · Lung Cancer · Melanoma · Gynecologic Cancer
Canada
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)Recruiting
NCT07221474Phase 2Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Squamous Non-small Cell Lung Cancer
United States, Argentina, Australia, Chile, France +6 more
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruiting
NCT06172478Phase 2Updated Aug 21, 2026
Sponsor: Daiichi Sankyo
Advanced Solid Tumor · Melanoma · Head and Neck Cancer · Gastric Cancer
United States, Australia, Belgium, Canada, China +11 more
The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerNot Yet Recruiting
NCT07780578Phase 2Updated Aug 21, 2026
Sponsor: Fudan University
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
China
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerActive Not Recruiting
NCT05132075Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Non-Small Cell Lung Cancer
United States, Argentina, Australia, Canada, China +20 more
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsRecruiting
NCT07109726Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Terremoto Biosciences Inc.
Breast Cancer · Endometrial Cancer · Ovarian Cancer · Lung Squamous Cell Carcinoma
United States, Puerto Rico
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)Recruiting
NCT07531095Phase 1Updated Aug 21, 2026
Sponsor: Amgen
Small Cell Lung Cancer
United States, Australia, Belgium, France, Germany +4 more
SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung CancerNot Yet Recruiting
NCT07322341Phase 2Updated Aug 21, 2026
Sponsor: University of Washington
Advanced Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · Recurrent Lung Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8
United States
A Phase 1 Study of LNCB74 in Advanced Solid TumorsRecruiting
NCT06774963Phase 1Updated Aug 21, 2026
Sponsor: NextCure, Inc.
Ovarian Cancer · Breast Cancer · Endometrial Cancer · Biliary Tract Cancer
United States
The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and ProgressionRecruiting
NCT07779005N/AUpdated Aug 21, 2026
Sponsor: Shengjing Hospital
Lung Caner
China
A Study of ZL-1310 in Subjects With Small Cell Lung CancerRecruiting
NCT06179069Phase 1Updated Aug 21, 2026
Sponsor: Zai Lab (Shanghai) Co., Ltd.
SCLC
United States, China, Spain
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerRecruiting
NCT05061550Phase 2Updated Aug 21, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Belgium, Canada, France, Hungary +7 more
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesRecruiting
NCT03965234Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Roswell Park Cancer Institute
Metastatic Bone Sarcoma · Metastatic Malignant Neoplasm in the Lung · Metastatic Soft Tissue Sarcoma · Metastatic Unresectable Sarcoma
United States
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory DiseaseNot Yet Recruiting
NCT07509034Phase 1Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Extensive-Stage Small Cell Lung Cancer · Extrapulmonary Neuroendocrine Carcinoma · Recurrent or Refractory · Solid Tumors
United States
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Recruiting
NCT07190248Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +24 more
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsActive Not Recruiting
NCT04579380Phase 2Updated Aug 21, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Uterine Neoplasms · Uterine Cervical Neoplasms · Biliary Tract Neoplasms · Urologic Neoplasms
United States, Belgium, Germany, Italy, Japan +3 more
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)Recruiting
NCT06312137Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
A Community Health Worker Intervention to Improve Lung Cancer Screening Uptake in Community Health CentersRecruiting
NCT07168629NAUpdated Aug 21, 2026
Sponsor: Baystate Medical Center
Lung Cancer · Tobacco Use
United States

14,461 studies found